Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global SNP Genotyping and Analysis Market Size study, by Product (Consumables/Reagent, Instruments, Services), by Technology (Taqman allelic discrimination, Microarrays & SNP genechips, Sequenom MassARRAY MALDI-TOF, Applied biosciences (AB) SNPlex, SNP pyrosequencing, Others), by Application (Pharmacogenomics & Pharmaceuticals, Diagnostic Research, Breeding & Animal livestock, Agricultural Biotechnology) and Regional Forecasts 2020-2026

  • BIZ3837215
  • 200 Pages
  • April 2020
  • Healthcare
Download Sample    Get Discount   
 
Global SNP Genotyping and Analysis Market is valued approximately at USD 15 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 21% over the forecast period 2020-2026. Single Nucleotide Polymorphisms (SNP) genotyping is the practice of screening and examining of genetic variations of SNPs between members of a species. The use of SNP genotyping is rapidly growing from personalized genetic testing to plant and animal biotechnology. Since, it helps in identifying the correlations between the genotype and behavior revealed by all living organisms. Further, SNP genotyping also gives an idea about the human genome classification and transfer of hereditary diseases. Thus, it is gaining a huge value in the pharmaceutical and medical fields, as it predicts disease association and the individual’s response for specific medication. Unlike the conventional time-consuming, labor-extensive and expensive detection technologies, SNP technology is considering as a highly efficient, relatively economical, and automated technology for genetic screening. Growing prevalence of incurable diseases such as cancer, diabetes and more, escalating demand for genetic analysis in animal and plant feedstock, and the high availability of private and public funding programs for genetics are the few factors responsible for high CAGR of the market over the forecast period. According to the International Diabetic Federation (IDF), the number of adults with diabetes was estimated around 415 million in 2015, and this number is projected to grow to almost 578 million by 2030, globally. Similarly, IDF also estimated that the number of diabetic patients in Europe is likely to rise from nearly 33 million in 2010 to 38 million in 2030. This, in turn, is expected to accelerate the demand for SNP Genotyping and Analysis, thus contributing to the growth of the global market. However, lack of standardization and privacy concerns in SNP process are the few factors expected to hamper the growth of the market over the forecast period of 2020-2026.

The regional analysis of global SNP Genotyping and Analysis market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the favorable government policies towards proper diagnosis and treatment of fatal diseases, along with the presence of extreme advanced technologies in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to rise in incidences of targeted diseases and growing healthcare facilities in the countries like China and India.

Major market player included in this report are:

Sequenom, Inc.

Douglas Scientific LLC

PREMIER Biosoft

Luminex Corp.

Life Technologies Corp.

Fluidigm Corporation

Illumina, Inc.

Affymetrix, Inc.

Promega Corporation

Thermo Fischer Scientific Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Consumables/Reagent

Instruments

Services

By Technology:

Taqman allelic discrimination

Microarrays & SNP genechips

Sequenom MassARRAY

MALDI-TOF

Applied biosciences (AB) SNPlex

SNP pyrosequencing

Others

By Application:

Pharmacogenomics & Pharmaceuticals

Diagnostic Research

Breeding & Animal livestock

Agricultural Biotechnology

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018

Base year – 2019

Forecast period – 2020 to 2026

Target Audience of the Global SNP Genotyping and Analysis Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)

1.2.1. SNP Genotyping and Analysis Market, by Region, 2018-2026 (USD Billion)

1.2.2. SNP Genotyping and Analysis Market, by Product, 2018-2026 (USD Billion)

1.2.3. SNP Genotyping and Analysis Market, by Technology, 2018-2026 (USD Billion)

1.2.4. SNP Genotyping and Analysis Market, by Application, 2018-2026 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global SNP Genotyping and Analysis Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global SNP Genotyping and Analysis Market Dynamics

3.1. SNP Genotyping and Analysis Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global SNP Genotyping and Analysis Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global SNP Genotyping and Analysis Market, by Product

5.1. Market Snapshot

5.2. Global SNP Genotyping and Analysis Market by Product, Performance - Potential Analysis

5.3. Global SNP Genotyping and Analysis Market Estimates & Forecasts by Product 2016-2026 (USD Billion)

5.4. SNP Genotyping and Analysis Market, Sub Segment Analysis

5.4.1. Consumables/Reagent

5.4.2. Instruments

5.4.3. Services

Chapter 6. Global SNP Genotyping and Analysis Market, by Technology

6.1. Market Snapshot

6.2. Global SNP Genotyping and Analysis Market by Technology, Performance - Potential Analysis

6.3. Global SNP Genotyping and Analysis Market Estimates & Forecasts by Technology 2016-2026 (USD Billion)

6.4. SNP Genotyping and Analysis Market, Sub Segment Analysis

6.4.1. Taqman allelic discrimination

6.4.2. Microarrays & SNP genechips

6.4.3. Sequenom Massarray

6.4.4. MALDI-TOF

6.4.5. Applied biosciences (AB) SNPlex

6.4.6. SNP pyrosequencing

6.4.7. Others

Chapter 7. Global SNP Genotyping and Analysis Market, by Application

7.1. Market Snapshot

7.2. Global SNP Genotyping and Analysis Market by Application, Performance - Potential Analysis

7.3. Global SNP Genotyping and Analysis Market Estimates & Forecasts by Application 2016-2026 (USD Billion)

7.4. SNP Genotyping and Analysis Market, Sub Segment Analysis

7.4.1. Pharmacogenomics & Pharmaceuticals

7.4.2. Diagnostic Research

7.4.3. Breeding & Animal livestock

7.4.4. Agricultural Biotechnology

Chapter 8. Global SNP Genotyping and Analysis Market, Regional Analysis

8.1. SNP Genotyping and Analysis Market, Regional Market Snapshot

8.2. North America SNP Genotyping and Analysis Market

8.2.1. U.S. SNP Genotyping and Analysis Market

8.2.1.1. Product breakdown estimates & forecasts, 2016-2026

8.2.1.2. Technology breakdown estimates & forecasts, 2016-2026

8.2.1.3. Application breakdown estimates & forecasts, 2016-2026

8.2.2. Canada SNP Genotyping and Analysis Market

8.3. Europe SNP Genotyping and Analysis Market Snapshot

8.3.1. U.K. SNP Genotyping and Analysis Market

8.3.2. Germany SNP Genotyping and Analysis Market

8.3.3. Rest of Europe SNP Genotyping and Analysis Market

8.4. Asia-Pacific SNP Genotyping and Analysis Market Snapshot

8.4.1. China SNP Genotyping and Analysis Market

8.4.2. India SNP Genotyping and Analysis Market

8.4.3. Japan SNP Genotyping and Analysis Market

8.4.4. Rest of Asia Pacific SNP Genotyping and Analysis Market

8.5. Latin America SNP Genotyping and Analysis Market Snapshot

8.5.1. Brazil SNP Genotyping and Analysis Market

8.5.2. Mexico SNP Genotyping and Analysis Market

8.6. Rest of The World SNP Genotyping and Analysis Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Sequenom, Inc.

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Product Summary

9.2.1.5. Recent Developments

9.2.2. Douglas Scientific LLC

9.2.3. PREMIER Biosoft

9.2.4. Luminex Corp.

9.2.5. Life Technologies Corp.

9.2.6. Fluidigm Corporation

9.2.7. Illumina, Inc.

9.2.8. Affymetrix, Inc.

9.2.9. Promega Corporation

9.2.10. Thermo Fischer Scientific Inc.

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

List of Tables

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL SNP GENOTYPING AND ANALYSIS MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL SNP GENOTYPING AND ANALYSIS MARKET

TABLE 3. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)

TABLE 7. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD BILLION)

TABLE 8. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD BILLION)

TABLE 9. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)

TABLE 10. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 11. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 12. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 13. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 14. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 15. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 16. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 17. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 18. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 19. GLOBAL SNP GENOTYPING AND ANALYSIS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 20. U.S. SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 21. U.S. SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 22. U.S. SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 23. CANADA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 24. CANADA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 25. CANADA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 26. UK SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 27. UK SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 28. UK SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 29. GERMANY SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 30. GERMANY SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 31. GERMANY SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 32. ROE SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 33. ROE SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 34. ROE SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 35. CHINA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 36. CHINA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 37. CHINA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 38. INDIA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 39. INDIA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 40. INDIA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 41. JAPAN SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 42. JAPAN SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 43. JAPAN SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 44. ROAPAC SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 45. ROAPAC SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 46. ROAPAC SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 47. BRAZIL SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 48. BRAZIL SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 49. BRAZIL SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 50. MEXICO SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 51. MEXICO SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 52. MEXICO SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 53. ROLA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 54. ROLA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 55. ROLA SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 56. ROW SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 57. ROW SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 58. ROW SNP GENOTYPING AND ANALYSIS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
View Details
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
View Details
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research